Evidence map›Paper›PMID 30018551›Full record

ArticleFrontiers in pharmacology2018

Pharmacodynamics of the Glutamate Receptor Antagonists in the Rat Barrel Cortex.

Daria Vinokurova, Andrey V Zakharov, Julia Lebedeva, Gulshat F Burkhanova, Kseniya A Chernova, Nailya Lotfullina, Rustem Khazipov, Guzel Valeeva

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Depth-profile of impairments in endothelin-1 - induced focal cortical ischemia.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Daria VinokurovaLaboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
Andrey V ZakharovLaboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
Julia LebedevaLaboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
Gulshat F BurkhanovaLaboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
Kseniya A ChernovaLaboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
Nailya LotfullinaLaboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
Rustem KhazipovLaboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
Guzel ValeevaLaboratory of Neurobiology, Kazan Federal University, Kazan, Russia.
Kazan Federal University · RUAix-Marseille Université · FRInstitut de Neurobiologie de la Méditerranée · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epipial application is one of the approaches for drug delivery into the cortex. However, passive diffusion of epipially applied drugs through the cortical depth may be slow, and different drug concentrations may be achieved at different rates across the cortical depth. Here, we explored the pharmacodynamics of the inhibitory effects of epipially applied ionotropic glutamate receptor antagonists CNQX and dAPV on sensory-evoked and spontaneous activity across layers of the cortical barrel column in urethane-anesthetized rats. The inhibitory effects of CNQX and dAPV were observed at concentrations that were an order higher than in slices

Indexed as

barrel cortexdrug deliveryepipial applicationfast oscillationsglutamate receptor antagonistssensory-evoked potentialslow wave activity

Identifiers

PMID30018551
PMCPMC6038834
OpenAlexW2807916493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.